Effectiveness and cost of selective decontamination of the digestive tract in critically III intubated patients: A randomized, double-blind, placebo-controlled, multicenter trial

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 3, 1998, Pages 908-916

  Sánchez García, Miguel ^a   Cambronero Galache, José A ^b   López Diaz, Julia ^b   Cerdá Cerdá, Enrique ^b   Rubio Blasco, José ^b   Gómez Aguinaga, Miguel A ^b   Núñez Reiz, Antonio ^b   Rogero Marín, Santiago ^b   Oñoro Cañaveral, Juan J ^b   Sacristán Del Castillo, José A ^b  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM DETECTION; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CRITICAL ILLNESS; ENDOTRACHEAL INTUBATION; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PNEUMONIA; PRIORITY JOURNAL;

EID: 0004879322     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.3.9712079     Document Type: Article

References (49)

1. Torres, A., R. Aznar, J. M. Gatell, P. Jimenez, J. Gonzalez, A. Ferrer, R. Celis, and R. Rodriguez-Roisin. 1990. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am. Rev. Respir. Dis. 142:523-528.
2. Rodriguez, J. L., K. J. Gibbons, L. G. Bitzer, R. E. Dechert, St. M. Steinberg, and L. M. Flint. 1991. Pneumonia: incidence, risk factors, and outcome in injured patients. J. Trauma 31:907-914.
3. Chevret, S., M. Hemmer, J. Carlet, M. Langer, and the European Cooperative Group on Nosocomial Pneumonia. 1993. Incidence and risk factors of pneumonia acquired in intensive care units. Intensive Care Med. 19:256-264.
4. Vincent, J. L., D. J. Bihari, P. M. Suter, H. A. Bruining, J. White, M. H. Nicolas-Chanoin, M. Wolff, R. C. Spencer, and M. Hemmer. 1995. The prevalence of nosocomial infection in intensive care units in Europe: results of the european prevalence of infection in intensive care (EPIC) study. J.A.M.A. 274:639-644.
5. George, D. L. 1993. Epidemiology of nosocomial ventilator-associated pneumonia. Infect. Control Hosp. Epidemiol. 14:163-169.
6. Fagon, J. Y., J. Chastre, A. Vuagnat, J. L. Trouillet, A. Novara, and C. Gibert. 1996. Nosocomial pneumonia and mortality among patients in intensive care units. J.A.M.A. 275:866-869.
7. Martone, W. J., W. R. Jarvis, D. H. Culver, and R. W. Haley. 1993. Incidence and nature of endemic and epidemic nosocomial infections. In J. V. Bennett and P. S. Brachman, editors. Hospital Infections, 3rd ed. Little, Brown, Boston. 577-596.
8. Johanson, W. G., A. K. Pierce, J. P. Sanford, and G. D. Thomas. 1972. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann. Intern. Med. 77: 701-706.
9. Garrouste-Orgeas, M., S. Chevret, G. Arlet, O. Marie, M. Rouveau, N. Popoff, and B. Schlemmer. 1997. Oropharyngeal and gastric colonization and nosocomial pneumonia in adult intensive care unit patients: a prospective study based on genomic DNA analysis. Am. Rev. Respir. Dis. 156:1647-1655.
10. Torres, A., M. El-Ebiary, J. González, M. Ferrer, J. Puig de la Bellacasa, A. Gene, A. Martos, and R. Rodriguez-Roisin. 1993. Gastric and pharyngeal flora in nosocomial pneumonia acquired during mechanical ventilation. Am. Rev. Respir. Dis. 148:352-357.
11. Van Saene, H. K. F., C. P. Stoutenbeek, and C. A. Hart. 1991. Selective decontamination of the digestive tract (SDD) in intensive care patients: a critical evaluation of the clinical, bacteriological and epidemiological benefits. J. Hosp. Infect. 18:261-277.
12. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. 1993. Meta-analysis of randomized controlled trials of selective decontamination of the digestive tract. B.M.J. 307:525-532.
13. Heyland, D. K., D. J. Cook, R. Jaeschke, L. Griffith, H. N. Lee, and G. H. Guyatt. 1994. Selective decontamination of the digestive tract: an overview. Chest 105:1221-1229.
14. Kollef, M. H. 1994. The role of selective digestive tract decontamination on mortality and respiratory tract infections: a meta-analysis. Chest 105:1101-1108.
15. Petros, A. J., J. C. Marshall, and H. K. F. Van Saene. 1995. Should morbidity replace mortality as an endpoint for clinical trials in intensive care? Lancet 345:369-371.
16. Knaus, W. A., E. A. Draper, D. P. Wagner, and J. E. Zimmerman. 1985. APACHE II: a severity of disease classification system. Crit. Care Med. 13:818-829.
17. Lennette, E. H., A. Balows, W. J. Hausler, and H. J. Shadomy. 1985. Manual of Clinical Microbiology, 4th ed. American Society for Microbiology, Washington DC. 978-987.
18. Prod'hom, G., P. Leuenberger, J. Koerfer, A. Blum, R. Chiolero, M. D. Schaller, C. Perret, O. Spinnler, J. Blondel, H. Siegrist, L. Saghafi, D. Blanc, and P. Francoli. 1994. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann. Intern. Med. 120:653-662.
19. Centers for Disease Control and Prevention. 1994. Guideline for prevention of nosocomial pneumonia. Respir. Care 39:1191-1236.
20. Niederman, M. S., A. Torres, and W. Summer. 1994. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 150:565-569.
21. Van Saene, H. K. F., V. Damjanovic, A. E. Murray, and M. A. de la Cal. 1996. How to classify infections in intensive care units - the carrier state, a criterion whose time has come? J. Hosp. Infect. 33:1-12.
22. D'Amico, R., S. Pifferi, C. Leonetti, V. Torri, A. Tinazzi, and A. Liberati. 1998. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomized controlled trials. B.M.J. 316:1275-1285.
23. Britt, M. R., C. J. Schleupner, and S. Matsumiya. 1978. Severity of underlying disease as a predictor of nosocomial infection: utility in the control of nosocomial infection. J.A.M.A. 239:1047-1051.
24. Brun-Buisson, C., P. Legrand, A. Rauss, C. Richard, F. Montravers, M. Besbes, J. L. Meakins, C. J. Soussy, and F. Lemaire. 1989. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli: study of an outbreak in an intensive care unit. Ann. Intern. Med. 110:873-881.
25. Kerver, A. J. H., J. H. Rommes, E. A. E. Mevissen-Verhage, P. F. Hulstaert. A. Vos, J. Verhoef, and P. Wittebol. 1988. Prevention of colonization and infection in critically ill patients: a prospective randomized study. Crit. Care Med. 16:1087-1093.
26. Jarvis, W. R., J. R. Edwards, D. H. Culver, J. M. Hughes, T. Horan, T. G. Emori, S. Banerjee, J. Toison, T. Henderson, R. P. Gaynes, and W. J. Martone. 1991. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am. J. Med. 91(Suppl. 3B): 185S-191S.
27. Baxby, D., H. K. F. Van Saene, C. P. Stoutenbeek, and D. F. I. Zandstra. 1996. Selective decontamination of the digestive tract: 13 years on, what it is and what it is not. Intensive Care Med. 22:699-706.
28. Siegel, J. E., M. C. Weinstein, L. B. Russell, and M. R. Gold. 1996. Recommendations for reporting cost-effectiveness analyses. J.A.M.A. 276: 1339-1341.
29. Cockerill, F. R., III, S. R. Muller, J. P. Anhalt, H. M. Marsh, M. B. Farnell, P. Mucha, D. J. Gillespie, D. M. Ilstrup, J. J. Larson-Keller, and R. L. Thompson. 1992. Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Ann. Intern. Med. 117:545-553.
30. Rocha, L. A., M. J. Martin, S. Pita, J. Paz, C. Seco, L. Margusino, R. Villanueva, and M. T. Duran. 1992. Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. Intensive Care Med. 18:398-404.
31. Korinek, A. M., M. J. Laisne, M. H. Nicolas, L. Raskine, V. Deroin, and M. J. Sanson-Lepors. 1993. Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit. Care Med. 21:1466-1473.
32. Langlois-Karaga, A., M. Bues-Charbit, A. Davignon, J. Albanese, O. Durbec, C. Martin, N. Morati, and G. Balansard. 1995. Selective decontamination in multiple trauma patients: cost and efficacy. Pharm. World Sci. 17:12-16.
33. Singer, M., S. Myers, G. Hall, S. L. Cohen, and R. F. Armstrong. 1994. The cost of intensive care: a comparison in one unit between 1988 and 1991. Intensive Care Med. 20:542-549.
34. Markowsky, S. J., and J. Christie. 1994. Pharmacoeconomics of selective decontamination of the digestive tract in intensive care patients: a US perspective. Pharmacoeconomics 5:361-366.
35. Van Saene, J. J. M., H. K. F. Van Saene, C. P. Stoutenbeek, and C. F. Lerck. 1985. Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal. Scand. J. Infect. Dis. 17:295-300.
36. Zobel, G., M. Kuttnig, H. M. Grubbauer, H. J. Semmelrock, and W. Thiel. 1991. Reduction of colonization and infection rate during pediatric intensive care by selective decontamination of the digestive tract. Crit. Care Med. 19:1242-1246.
37. Sun, X., D. P. Wagner, and W. A. Knaus. 1996. Does selective decontamination of the digestive tract reduce mortality for severely ill patients? Crit. Care Med. 24:753-755.
38. Lortholary, O., J. Y. Fagon, A. B. Hoi, M. A. Slama, J. Pierre, P. Giral, R. Rosenzweig, L. Gutman, M. Safar, and J. Acar. 1995. Nosocomial acquisition of multiresistant Acinetobacter baumanii: risk factors and prognosis. Clin. Infect. Dis. 20:790-796.
39. Garrouste-Orgeas, M., O. Marie, M. Rouveau, S. Villiers, G. Arlet, and B. Schlemmer. 1996. Secondary carriage with multi-resistant Acinetobacter baumanii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infections and mortality. J. Hosp. Infect. 34:279-289.
40. Vollaard, E. J., and H. A. L. Clasener. 1994. Colonization resistance. Antimicrob. Agents Chemother. 38:409-414.
41. Gastinne, H., M. Wolff, F. Delatour, F. Faurisson, and S. Chevret. 1992. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. N. Engl. J. Med. 326:594-599.
42. Hammond, J. M. J., P. D. Potgieter, G. L. Saunders, and A. A. Forder. 1992. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 340:5-9.
43. Ferrer, M., A. Torres, J. Gonzalez, J. Puig de la Bellacasa, M. El-Ebiary, M. Roca, J. M. Gatell, and R. Rodriguez-Roisin. 1994. Utility of selective digestive decontamination in mechanically ventilated patients. Ann. Intern. Med. 120:389-395.
44. Verwaest, C., J. Verhaegen, P. Ferdinande, M. Schetz, G. Van der Berghe, L. Verbist, and P. Lauwers. 1997. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit. Care Med. 25:63-71.
45. Wiener, J., G. Itokazu, C. Nathan, S. A. Kabins, and R. A. Weinstein. 1995. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin. Infect. Dis. 20:861-867.
46. Hammond, J. M. J., and P. D. Potgieter. 1995. Long-term effect of selective decontamination on microbial resistance. Crit. Care Med. 23:637-645.
47. Kaufhold, A., W. Behrendt, T. Kräuss, and H. K. F. van Saene. 1992. Selective decontamination of the digestive tract and methicillin-resistant S. aureus. Lancet 339:1411-1412.
48. Fink, M. P., D. R. Snydman, M. S. Niederman, K. V. Leeper, Jr., R. H. Johnson, S. O. Heard, R. G. Wunderink, J. W. Caldwell, J. J. Schentag, G. A. Siami, R. L. Zameck, D. C. Flaverstock, H. H. Reinhart, R. M. Echols, and The Severe Pneumonia Study Group. 1994. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob. Agents Chemother. 38: 547-557.
49. Stoutenbeek, C. P., H. K. F. van Saene, and D. F. Zandstra. 1987. The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J. Antimicrob. Chemother. 19:513-520.